Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy
Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy
Recruiting · NCT05858983 · Registry updated 2023-05-15Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Gene Therapy in Subjects With Biallelic RPE65 Mutation-associated Retinal Dystrophy | Biallelic RPE65 Mutation-associated Retinal Dystrophy | Recruiting | Phase 1 / Phase 2 | 2023-05-15 | NCT05858983 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Frontera Therapeutics | 6 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Peking Union Medical College Hospital | Beijing | China | 4 |